Internal Control · 2025
In this section9 topics
- Internal Control — Board Opinion1 item
- Adequacy & Appropriateness of the Internal Control System1 item
- Internal Control Deficiencies1 item
- Audit Committee & Auditor Observations2 items
- Opinion on the Head of Internal Audit2 items
- Appointment, Discharge & Transfer of the Head of Internal Audit2 items
- Related Party Transactions1 item
- Counterparties & Transactions3 items
- Policy & Future Trends2 items
Internal Control — Board Opinion
Summary of the Board's Opinion on Internal Control
At Board of Directors Meeting No. 1/2026 on 25 February 2026, with all three Audit Committee members in attendance, the Board considered and assessed the adequacy of the Company’s internal control system pursuant to the SEC’s internal control adequacy assessment form, and made inquiries of management regarding the Company’s internal controls in various aspects in accordance with the COSO (The Committee of Sponsoring Organizations of Treadway Commission) framework. The Board of Directors is of the opinion that the Company has an adequate and appropriate internal control system, with sufficient personnel to implement the system effectively, enabling operations in accordance with Good Corporate Governance with transparency. The Company also has a monitoring system to ensure protection of Company assets from unauthorized use by directors or executives, as well as adequate controls for transactions with potentially conflicted or related persons. Please refer to Attachment 6 for additional details.
Adequacy & Appropriateness of the Internal Control System
Internal Control Framework Used
| Framework | Detail |
|---|---|
| COSO - Enterprise Risk Management Framework (ERM) | The Group has an Audit Committee responsible for overseeing and reviewing the Company’s internal control and internal audit systems to be appropriate, transparent, and effective, as well as monitoring compliance with the Securities and Exchange Act, SET requirements, and relevant business laws. The Audit Committee meets at least quarterly to consider the accuracy and completeness of financial reports, material information disclosure, and related party transactions or potential conflicts of interest, in compliance with the Capital Market Supervisory Board and SET requirements, with auditors attending to clarify audit results and provide relevant observations. For internal control, the Company and subsidiaries have engaged August Audit and Consult Co., Ltd. (the “Independent Internal Auditor”) to audit and assess the Group’s internal control system. The Independent Internal Auditor commenced operations in 2025 and has continuously monitored progress on process and internal control improvements throughout 2025. |
Internal Control Deficiencies
Number of Deficiencies
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of internal control system deficiencies (cases) | 0 | 0 | 0 |
Audit Committee & Auditor Observations
Audit Committee's Opinion Differs from the Board's
No
Auditor Has Observations on Internal Control
No
Opinion on the Head of Internal Audit
Head of Internal Audit
3160
Audit Committee's Opinion on the Head of Internal Audit
At Audit Committee Meeting No. 1/2025 on 20 February 2025, the Audit Committee approved the appointment of August Audit and Consult Co., Ltd. to audit and assess the Company’s internal control system. August Audit and Consult Co., Ltd. assigned Ms. Rattanawadee Thiamyot to serve as the Company’s Head of Internal Audit. The Audit Committee considered that Ms. Rattanawadee Thiamyot is suitable for the position based on her educational qualifications, work experience, and completion of relevant internal audit training courses.
Please refer to Attachment 3 for additional details on the qualifications of the Head of Internal Audit.
Appointment, Discharge & Transfer of the Head of Internal Audit
Requires Audit Committee Approval
Yes
Description
The appointment, removal, and transfer of the person holding the position of Head of Internal Audit must receive the consent and approval of the Audit Committee, to consider qualifications and suitability to perform the duties of the Head of Internal Audit effectively, based on educational qualifications, experience, and completion of relevant training courses.
Related Party Transactions
Has Related Party Transactions
Yes
Counterparties & Transactions
Monetary Unit
1000000
Counterparties with Potential Conflicts
| Name | Person / Juristic Person | Type of Business | Nature of Relationship | As of Date (YYYY-MM-DD) |
|---|---|---|---|---|
| Wanrat (Nam Sian) Company Limited | Juristic Person | Distribution of chemicals for cosmetics, food, and pharmaceuticals | Joint shareholders | 2025-12-31T00:00 |
| Key Executives | Person | Persons with authority and responsibility for planning, directing, and controlling various activities of the enterprise, whether directly or indirectly. This includes the company's directors (whether performing executive duties or not). | 2025-12-31T00:00 | |
| Specialty Natural Innovation Company Limited | Juristic Person | Shareholding in other companies | Major shareholders and those with common directors with the company | 2025-12-31T00:00 |
| Panvipa Consulting Company Limited | Juristic Person | Providing research and development services for cosmetic products | Joint Shareholders and Directors | 2025-12-31T00:00 |
| Specialty Biotech Company Limited | Juristic Person | Manufacture and distribute yeast extract | Joint Shareholders and Directors | 2025-12-31T00:00 |
| The Stardome Company Limited | Juristic Person | Condominium and Housing Estate Management | Joint Shareholders and Directors | 2025-12-31T00:00 |
| Star Stars Company Limited | Juristic Person | Engaged in the business of room rental | Joint Shareholders and Directors | 2025-12-31T00:00 |
| Pandollama Company Limited | Juristic Person | Providing business consulting services for all types of businesses | Joint Shareholders and Directors | 2025-12-31T00:00 |
| Dermscan Asia Company Limited | Juristic Person | Dermatological Product Testing Services | Joint shareholders and directors | 2025-12-31T00:00 |
| Kritsada Laboratory Company Limited | Juristic Person | Physical and Chemical Operational Testing and Analysis Services | Joint shareholders | 2025-12-31T00:00 |
| Star Builder Company Limited | Juristic Person | Sale and Rental of Residential Real Estate | Joint Directors | 2025-12-31T00:00 |
| L Solar 3 Company Limited | Juristic Person | Electricity Generation and Distribution | Indirectly Associated Company | 2025-12-31T00:00 |
Transactions by Counterparty
| Transactions |
|---|
| 60.84 · Necessity: SNPS operates by selling products such as herbal extracts, raw materials for cosmetics and cosmeceuticals, as well as resold goods, to Wanrat (Nam Sian) Company Limited (“NSG”), which acts as the distributor for the company's products. The selling price of products to NSG is based on the company's Price List for distributors, which is lower than the price offered to general customers. This is because NSG, as a distributor, is responsible for conducting marketing and sales promotion activities for the company's products, such as preparing information and media for sales promotion, presenting products to customers, developing customer networks, and providing customer services like product delivery. According to the distributorship agreement, NSG is required to submit reports on its marketing activities, market developments, and customer demand trends to the company at least once a year. However, in practice, SNPS and NSG regularly report such information through quarterly joint meetings. During these meetings, data on sales orders, market demand trends, and customer feedback are consistently updated to be used for the company's product development and marketing planning. · Description: SNPS has appointed Wanarat (Nam Sian) Co., Ltd. as the distributor for the company's products in Thailand. This is because Wanarat (Nam Sian) Co., Ltd. has been engaged in the business of distributing raw materials to manufacturers in the cosmetics, food, and pharmaceutical industries for over 90 years. Consequently, it possesses an extensive customer network and maintains continuous strong business relationships with numerous manufacturers and raw material suppliers in these industries. Furthermore, Wanarat (Nam Sian) Co., Ltd. has been a business partner of the company since its inception. Therefore, it possesses a thorough understanding of the products and related markets, enabling it to effectively support the company's market expansion and reach its target customer groups. · As of yesteryear: 33.86 · Nature of transaction: Revenue from Sales · Audit committee opinion: The aforementioned transaction is considered a normal course of business for Specialty Natural Products Public Company Limited ("SNPS"), where the selling price of products to Wanrat (Nam Sian) Company Limited is in accordance with the Company's Price List for distributors, which is lower than the price offered to general customers. This is because Wanrat (Nam Sian) Company Limited, as a distributor, is responsible for conducting promotional activities for the Company's products, such as preparing information and media for sales promotion, presenting products to customers, building customer networks, as well as providing services to customers, such as product delivery. Therefore, the Company considers that the aforementioned transaction is in accordance with appropriate commercial terms and is reasonable and consistent with the Company's normal course of business. · As of year before yesteryear: 37.88 · 8.75 · Necessity: SNPS sells products such as herbal extracts, raw materials for cosmetics and cosmeceuticals, and resold goods to Wanrat (Nam Sian) Company Limited (“NSG”), which acts as the distributor for the company's products. The selling price of products to NSG is based on the company's Price List for distributors, which is lower than the price offered to general customers. This is because NSG, as a distributor, is responsible for conducting marketing and sales promotion activities for the company's products, such as preparing information and media for sales promotion, presenting products to customers, developing customer networks, and providing customer services like product delivery. According to the distributor appointment agreement, NSG is required to submit reports on its marketing activities, market developments, and customer demand trends to the company at least once a year. However, in practice, SNPS and NSG regularly report this information through quarterly joint meetings, consistently updating data on product order volumes, market demand trends, and customer feedback. This information is then used for the company's product development and marketing planning. · Description: SNPS has appointed Wanarat (Nam Sian) Co., Ltd. as the distributor for the company's products in Thailand. This is because Wanarat (Nam Sian) Co., Ltd. has been engaged in the business of distributing raw materials to manufacturers in the cosmetics, food, and pharmaceutical industries for over 90 years. Consequently, it possesses an extensive customer network and maintains continuous strong business relationships with numerous manufacturers and raw material suppliers in these industries. Furthermore, Wanarat (Nam Sian) Co., Ltd. has been a business partner of the company since its inception. Therefore, it possesses a thorough understanding of the products and related markets, enabling it to effectively support the company's market expansion and reach its target customer groups. · As of yesteryear: 7.79 · Nature of transaction: Accounts Receivable · Audit committee opinion: The aforementioned transaction is considered a normal course of business for Specialty Natural Products Public Company Limited ("SNPS"), where the selling price of products to Wanrat (Nam Sian) Company Limited is in accordance with the Company's Price List for distributors, which is lower than the price offered to general customers. This is because Wanrat (Nam Sian) Company Limited, as a distributor, is responsible for conducting promotional activities for the Company's products, such as preparing information and media for sales promotion, presenting products to customers, building customer networks, as well as providing services to customers, such as product delivery. Therefore, the Company considers that the aforementioned transaction is in accordance with appropriate commercial terms and is reasonable and consistent with the Company's normal course of business. · As of year before yesteryear: 2.49 · 0.03 · Necessity: SNPS provides product packaging (repack) and product analysis services to NSG. The service fees charged to NSG are comparable to transactions with third parties and are under normal trade conditions. · Description: SNPS provides product packaging (repack) and product analysis services to NSG. The service fees charged to NSG are comparable to transactions with third parties and are under normal trade conditions. · As of yesteryear: 0.03 · Nature of transaction: Service Revenue · Audit committee opinion: The aforementioned transactions constitute ordinary business operations of SNPS and SI. The service fees charged to the related companies are comparable to those for transactions with external parties and are under normal commercial terms. Consequently, these transactions are deemed appropriate and reasonable. · As of year before yesteryear: 0.05 · 2.2 · Necessity: SNPS purchases chemical products from NSG to provide comprehensive services to customers. The purchase price of these raw materials is comparable to or lower than prices from third parties, and the trade terms are normal. · Description: SNPS purchases chemical products from NSG to provide comprehensive services to customers. The purchase price of these raw materials is comparable to or lower than prices from third parties, and the trade terms are normal. · As of yesteryear: 1.11 · Nature of transaction: Purchase of goods · Audit committee opinion: Such transactions are in the ordinary course of business for SNPS, with purchase prices comparable to or lower than those with third parties, and under normal commercial terms. Therefore, these transactions are deemed appropriate and reasonable. · As of year before yesteryear: 2.44 · 0.13 · Necessity: SNPS purchases chemical products from NSG to provide comprehensive services to customers. The purchase price of these raw materials is comparable to or lower than prices from third parties, and the trade terms are normal. · Description: SNPS purchases chemical products from NSG to provide comprehensive services to customers. The purchase price of these raw materials is comparable to or lower than prices from third parties, and the trade terms are normal. · As of yesteryear: 0.39 · Nature of transaction: Trade Creditors · Audit committee opinion: Such transactions are in the ordinary course of business for SNPS, with purchase prices comparable to or lower than those with third parties, and under normal commercial terms. Therefore, these transactions are deemed appropriate and reasonable. · As of year before yesteryear: 0.33 |
| The Group sells products to executives as a welfare benefit provided by the Group to all employees. The terms and conditions received by executives are the same as those received by all employees. Furthermore, the Group has clearly established written procedures regarding employee welfare benefits. · Description: The Group sells products to executives as a welfare benefit provided by the Group to all employees. The terms and conditions received by executives are the same as those received by all employees. Furthermore, the Group has clearly established written procedures regarding employee welfare benefits. · As of yesteryear: 0.03 · Nature of transaction: Revenue from Sales · Audit committee opinion: The aforementioned transaction constitutes a welfare benefit provided by the Group Company to all employees. The conditions received by the executives are identical to those received by all employees. Therefore, it is deemed appropriate. · As of year before yesteryear: 0.06 |
Policy & Future Trends
Policy, Measures & Approval Process
In entering into connected transactions by the Company or its subsidiaries, the Company shall comply with the Company's regulations, the Securities and Exchange Act, as well as the regulations, announcements, orders, or requirements of the Securities and Exchange Commission, the Capital Market Supervisory Board, the Stock Exchange of Thailand ("SET"), and any other relevant agencies. Furthermore, the Company shall comply with the disclosure requirements for connected transactions as stipulated under such regulations, announcements, orders, or requirements, including financial reporting standards prescribed by the Federation of Accounting Professions under the Royal Patronage and other related criteria. Interested parties shall not be permitted to participate in the consideration or approval of such transactions.
• (a) Connected transactions that are commercial agreements with general trading conditions. The Company's Board of Directors has approved in principle that management may approve connected transactions that are normal business operations or transactions supporting normal business operations, which involve commercial agreements with general trading conditions, such as buying or selling, providing or receiving services, etc. These transactions may be between the Company and/or its subsidiaries and directors, executives, or related persons of the Company, provided that such transactions have commercial terms similar to those that a prudent person would enter into with a general counterparty under the same circumstances, with bargaining power free from the influence of their status as a director, executive, or related person (as the case may be). The Company will prepare a summary report of inter-company transactions or connected transactions to be reported at the Company's Audit Committee meetings and Board of Directors meetings every quarter. This is to comply with the Securities and Exchange Act, regulations, announcements, orders, or requirements of the Securities and Exchange Commission, the Capital Market Supervisory Board, and the Stock Exchange of Thailand.
• (b) Other connected transactions. The Company has established measures for entering into connected transactions between the Company and its subsidiaries with persons who may have a conflict of interest. The Audit Committee will be responsible for providing opinions on the necessity, reasonableness, and price appropriateness of such transactions. This will be based on various conditions consistent with normal business practices at market prices, comparable to prices with third parties. In cases where the Audit Committee lacks expertise in considering potential connected transactions, the Company will engage individuals with specialized knowledge, such as auditors, asset appraisers, or law firms, who are independent of the Company and the persons who may have a conflict of interest, to provide opinions on such connected transactions. This information will be used by the Audit Committee for its decision-making, enabling the Audit Committee to present it to the Board of Directors or shareholders, as the case may be.
Future Trends in Related Party Transactions
Related party transactions of the Company or its subsidiaries may occur in the future. The Board of Directors has established a policy requiring the Company to comply with the Company's regulations, the Securities and Exchange Act, including regulations, announcements, orders, or requirements of the Securities and Exchange Commission, the Capital Market Supervisory Board, the Stock Exchange of Thailand ("SET"), and any other relevant agencies. Furthermore, the Company must adhere to the requirements concerning the disclosure of related party transactions in accordance with the criteria stipulated under such regulations, announcements, orders, or requirements, including financial reporting standards prescribed by the Federation of Accounting Professions under the Royal Patronage and other related criteria. Interested parties shall not be permitted to participate in the consideration and approval of such transactions.

